• Exchange: Mexico
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AMGN*:MM

1,883.00 MXN 39.30 2.13%

As of 16:09:22 ET on 09/18/2014.

Snapshot for Amgen Inc (AMGN*)

Open: 1,879.06 Day's Range: 1,879.06 - 1,883.00 Volume: 863
Previous Close: 1,843.70 52wk Range: 1,408.86 - 1,883.00 1-Yr Rtn: +29.08%

Stock Chart for AMGN*

No chart data available.
  • AMGN*:MM 1,883.00
  • 1D
  • 1M
  • 1Y
1,843.70
Interactive AMGN* Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AMGN*

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 16.9472
Relative P/E vs. MEXBOL -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 8.3890
Est. PEG Ratio 2.0490
Market Cap (M MXN) 1,430,340.41
Shares Outstanding (M) 759.61
30 Day Average Volume 261
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.71%
Cash Dividend (USD) 0.6100
Dividend Ex-Date 08/12/2014
5 Year Dividend Growth -
Next Earnings Announcement 10/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AMGN*

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AMGN*

Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

Robert A Bradway "Bob"Chairman/President/CEODavid W MelineExec VP/CFO
Anthony C Hooper "Tony"Exec VP:Global Commercial OpsBrian M McNameeExec VP:Full Potential Initiatives
More Company Profile & Key Executives for AMGN*

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil